Resolian Executive and Leadership Team

Robert Stachlewitz, the Chief Executive Officer at Resolian, directs the overarching corporate strategy and operational framework. Overseeing all functional departments, Stachlewitz ensures seamless integration of expertise from Alliance Pharma and Drug Development Solutions to advance therapeutic modalities. This leadership position involves driving innovation across the organization, fostering a culture of scientific excellence, and guiding the company's expansion into new markets. By aligning departmental objectives with the company's mission, Robert Stachlewitz champions the delivery of world-class scientific solutions. The Chief Executive Officer's responsibilities extend to stakeholder relations, investor communications, and long-term business development, solidifying Resolian's position as a leader in R&D services. Strategic planning for global operations falls under this executive's purview, ensuring efficient resource allocation and maximum impact.

Alexander Abramov, the Chief Financial Officer at Resolian, manages all financial operations and fiscal strategy. Overseeing budgeting, forecasting, and financial reporting, Abramov ensures robust financial health and compliance across the organization. This role involves strategic capital allocation, risk management, and optimizing financial performance to support the company's growth objectives. Alexander Abramov collaborates closely with other executive leaders to align financial planning with operational initiatives, particularly in integrating the financial systems of Alliance Pharma and Drug Development Solutions. The Chief Financial Officer's oversight extends to investment analysis and securing funding for research and development projects, directly impacting the company's ability to deliver cutting-edge therapeutic solutions. Ensuring fiscal discipline and transparency are paramount to Abramov's leadership.

Laixin Wang, the President, Site (China) at Resolian, spearheads operations and strategic development within the China region. Overseeing all site-specific functions, Wang ensures the effective implementation of Resolian's scientific solutions and therapeutic modalities in the Chinese market. This leadership role involves managing local teams, fostering key partnerships, and driving business growth in alignment with global corporate objectives. Laixin Wang's responsibilities include ensuring operational efficiency, regulatory compliance, and the seamless integration of local expertise with the broader company framework. The President, Site (China) plays a critical part in expanding Resolian's reach and impact, leveraging regional insights to enhance service delivery. Wang's focus remains on cultivating a high-performing environment that supports innovation and client success.

Jason Wang, the President, Site (Australia) at Resolian, leads all operational activities and strategic initiatives for the Australian site. Overseeing the execution of world-class scientific solutions, Wang ensures that Resolian's expertise in therapeutic modalities is effectively deployed across the region. This executive position involves managing local resources, cultivating strategic alliances, and driving market penetration to achieve ambitious growth targets. Jason Wang's mandate includes maintaining high standards of operational excellence, adhering to all regulatory requirements, and fostering a collaborative environment that integrates the Australian operations with the global company vision. The President, Site (Australia) is instrumental in extending Resolian's influence and delivering exceptional value to clients in the Australian market. Wang's leadership focuses on sustainable development and client satisfaction.